Literature DB >> 9473016

Identification of a site for a cohort study on natural history of HIV infection in Ethiopia.

T Sahlu1, A Fontanet, T Rinke de Wit, T Messele, R Doorly, H Yeneneh, P Bindels, R Coutinho.   

Abstract

A cross-sectional survey was carried out in a sugar estate in central Ethiopia to identify a subgroup for a cohort study on the natural history of HIV infection. HIV prevalence was 2.8% (95% confidence interval [CI], 1.7%-3.9%) in 957 adults aged 15 to 54 years randomly selected for the initial survey. A follow-up survey including only factory workers of the estate aged 18 to 45 years (n = 280) showed a higher HIV prevalence in male factory workers (n = 262) compared with the male estate workers of the same age of the initial survey (n = 484; 8.8% versus 3.1 %; p < .05). Factors independently associated with HIV infection in male factory workers were number of lifetime sexual partners, positive syphilis serology, higher income, and absence of travel outside the residential area. Among male estate workers, only older age was associated with HIV infection. Both factory workers and male estate workers were stable residents and were willing to participate in a long-term study on HIV/ AIDS. However, because of the higher HIV prevalence in factory workers and the higher prevalence of behaviors associated with an increased risk for HIV infection, factory workers were selected for the long-term cohort study on the natural history of HIV infection.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Africa; Africa South Of The Sahara; Cohort Analysis; Developing Countries; Diseases; Eastern Africa; Economic Factors; Ethiopia; Hiv Infections; Human Resources; Labor Force; Measurement; Prevalence; Research Methodology; Research Report; Viral Diseases

Mesh:

Year:  1998        PMID: 9473016     DOI: 10.1097/00042560-199802010-00008

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  6 in total

1.  Distribution of lymphocyte subsets in healthy human immunodeficiency virus-negative adult Ethiopians from two geographic locales.

Authors:  A Kassu; A Tsegaye; B Petros; D Wolday; E Hailu; T Tilahun; B Hailu; M T Roos; A L Fontanet; D Hamann; T F De Wit
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

2.  Use of dried spots of whole blood, plasma, and mother's milk collected on filter paper for measurement of human immunodeficiency virus type 1 burden.

Authors:  Workenesh Ayele; Rob Schuurman; Tsehaynesh Messele; Wendelien Dorigo-Zetsma; Yohannes Mengistu; Jaap Goudsmit; William A Paxton; Michel P de Baar; Georgios Pollakis
Journal:  J Clin Microbiol       Date:  2007-01-24       Impact factor: 5.948

3.  Tuberculin skin test conversion and reactivity rates among adults with and without human immunodeficiency virus in urban settings in Ethiopia.

Authors:  Belete Tegbaru; Dawit Wolday; Tsehaynesh Messele; Mengistu Legesse; Yared Mekonnen; Frank Miedema; Debbie van Baarle
Journal:  Clin Vaccine Immunol       Date:  2006-07

4.  Determinants of CD4 counts among HIV-negative Ethiopians: role of body mass index, gender, cigarette smoking, khat (Catha Edulis) chewing, and possibly altitude?

Authors:  C Abuye; A Tsegaye; C E West; P Versloot; E J Sanders; D Wolday; D Hamann; T F Rinke De Wit; A L Fontanet
Journal:  J Clin Immunol       Date:  2005-03       Impact factor: 8.317

5.  Indeterminate human immunodeficiency virus Western blot profiles in ethiopians with discordant screening-assay results.

Authors:  Hailu Meles; Dawit Wolday; Arnaud Fontanet; Aster Tsegaye; Tesfaye Tilahun; Mathias Aklilu; Eduard Sanders; Tobias F Rinke De Wit
Journal:  Clin Diagn Lab Immunol       Date:  2002-01

6.  Development of a nucleic acid sequence-based amplification assay that uses gag-based molecular beacons to distinguish between human immunodeficiency virus type 1 subtype C and C' infections in Ethiopia.

Authors:  Workenesh Ayele; Georgios Pollakis; Almaz Abebe; Bitew Fisseha; Belete Tegbaru; Girma Tesfaye; Yohannes Mengistu; Dawit Wolday; Bob van Gemen; Jaap Goudsmit; Wendelien Dorigo-Zetsma; Michel P de Baar
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.